Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Jiantao Kou is active.

Publication


Featured researches published by Jiantao Kou.


Hepatobiliary & Pancreatic Diseases International | 2012

Increase of peripheral Th17 lymphocytes during acute cellular rejection in liver transplant recipients

Hua Fan; Li-Xin Li; Dongdong Han; Jiantao Kou; Ping Li; Qiang He

BACKGROUND Although many human inflammatory and autoimmune diseases were previously considered to be mediated by T helper type 1 (Th1) cells, the recently described Th17 cells play dominant roles in several of these diseases. We and others speculated that allograft rejection after organ transplantation may also involve Th17 cells. Episodes of acute rejection occur in 30% of liver transplants. This study aimed to determine the frequency of circulating Th17 cells in patients who had received liver transplants for benign end-stage liver disease and to identify any association between acute rejection episodes and levels of Th17 cells in the peripheral blood. METHODS A prospective study compared Th17 cells from 76 consecutive benign end-stage liver disease patients who had undergone orthotopic liver transplantation from 2007 to 2011 with those from 20 age-matched healthy individuals. Peripheral blood samples were collected at different time points within one year after transplant. Blood samples and liver biopsies were also collected at the diagnosis of acute rejection. Percentages of circulating CD4+IL-17+ cells were measured by flow cytometry. The transplant patients were classified into two groups: a rejection group consisting of 17 patients who had an episode of acute rejection, and a non-rejection group comprising the remaining 59 patients with no acute rejection episodes. Percentages of circulating Th17 cells were compared between the two groups and controls. RESULTS The levels of circulating CD4+IL-17+ T cells in the rejection group were higher during acute rejection than those in the non-rejection group (2.56+/-0.43% versus 1.79+/-0.44%, P<0.001). The frequency of CD4+IL-17+ cells in peripheral blood was positively correlated with the rejection activity index (r=0.79, P=0.0002). CONCLUSION Circulating Th17 cells may be useful as a surrogate marker for predicting acute rejection in liver transplant recipients.


Journal of Gastroenterology and Hepatology | 2016

Resection of portal and/or superior mesenteric vein and reconstruction by using allogeneic vein for pT3 pancreatic cancer

Xing-mao Zhang; Hua Fan; Jiantao Kou; Xin-xue Zhang; Ping Li; Yang Dai; Qiang He

There is still controversy on the outcomes of portal vein (PV) and/or superior mesenteric vein (SMV) resection in pancreatic cancer, and there are few reports about pancreaticoduodenectomy (PD) with PV/SMV resection and reconstruction by using allogeneic vein. This study is to explore the outcomes of PD with PV/SMV resection and reconstruction by using allogeneic vein for pT3 pancreatic cancer with venous invasion.


Scientific Reports | 2015

Association between vitamin C intake and the risk of pancreatic cancer: a meta-analysis of observational studies

Hua Fan; Jiantao Kou; Dongdong Han; Ping Li; Dong Zhang; Qiao Wu; Qiang He

Quantification of the association between the intake of vitamin C and risk of pancreatic cancer is still conflicting. We therefore conducted a meta-analysis to assess the association between them. Pertinent studies were identified by a search of PubMed and Web of Knowledge throughSeptember of 2014. A random effects model was used to combine the data for analysis. Sensitivity analysis and publication bias were conducted. Data from 17 studies including 4827 pancreatic cancer cases were used in this meta-analysis. Pooled results suggested that highest vitamin C intake amount versus lowest amount was significantlyassociated with reduced the risk of pancreatic cancer [summary relative risk (RR) = 0.705, 95% CI = 0.612–0.811, I2 = 42.3%]. The associations were also significant both in Caucasian [summary RR = 0.741, 95% CI = 0.626–0.876], Asian [summary RR = 0.455, 95% CI = 0.275–0.754] and Mixed population [summary RR = 0.677, 95% CI = 0.508–0.901]. No publication bias was found. Our analysis suggested that the higher intake of vitamin C might reduce the risk of pancreatic cancer.


Hepatobiliary & Pancreatic Diseases International | 2017

Bilioenteric anastomotic stricture in patients with benign and malignant tumors: prevalence, risk factors and treatment

Jiqiao Zhu; Xian-Liang Li; Jiantao Kou; Hongmeng Dong; Huanye Liu; Chun Bai; Jun Ma; Qiang He

BACKGROUND Stricture formation at the bilioenteric anastomosis is a rare but important postoperative complication. However, information on this complication is lacking in the literature. In the present study, we aimed to assess its prevalence and predictive factors, and report our experience in managing bilioenteric anastomotic strictures over a ten-year period. METHODS A total of 420 patients who had undergone bilioenteric anastomosis due to benign or malignant tumors between February 2001 and December 2011 were retrospectively reviewed. Univariate and multivariate modalities were used to identify predictive factors for anastomotic stricture occurrence. Furthermore, the treatment of anastomotic stricture was analyzed. RESULTS Twenty-one patients (5.0%) were diagnosed with bilioenteric anastomotic stricture. There were 12 males and 9 females with a mean age of 61.6 years. The median time after operation to anastomotic stricture was 13.6 months (range, 1 month to 5 years). Multivariate analysis identified that surgeon volume (≤30 cases) (odds ratio: -1.860; P=0.044) was associated with the anastomotic stricture while bile duct size (>6 mm) (odds ratio: 2.871; P=0.0002) had a negative association. Balloon dilation was performed in 18 patients, biliary stenting in 6 patients, and reoperation in 4 patients. Five patients died of tumor recurrence, and one of heart disease. CONCLUSIONS Bilioenteric anastomotic stricture is an uncommon complication that can be treated primarily by interventional procedures. Bilioenteric anastomosis may be performed by a surgeon in his earlier training period under the guidance of an experienced surgeon. Bile duct size >6 mm may play a protective role.


Hepatobiliary & Pancreatic Diseases International | 2015

Predictors of incidental gallbladder cancer in elderly patients

Jiqiao Zhu; Dongdong Han; Xian-Liang Li; Jiantao Kou; Hua Fan; Qiang He

BACKGROUND At the time of diagnosis, most patients with gallbladder cancer are in advanced stage and the cancer is unresectable. Long-term survivors are usually seen in a small number of patients with incidental gallbladder cancer. This study aimed to identify preoperative predictors of incidental gallbladder cancer in elderly patients. METHODS A total of 4014 patients of more than 44 years old who had undergone cholecystectomy at our department from January 2000 to December 2010 were retrospectively reviewed. Univariate and multivariate modalities were used to identify the predictive factors of incidental gallbladder cancer. RESULTS Twenty-nine of the 4014 patients who had undergone cholecystectomy for benign gallbladder diseases were histologically diagnosed as having incidental gallbladder cancer. Multivariate analysis identified that elevated carbohydrate antigen 19-9 combined with carcinoembryonic antigen and/or carbohydrate antigen 125 (P=0.045), a gallbladder polyp greater than or equal to 1.2 cm (P=0.043) and focal gallbladder wall thickening of more than or equal to 5 mm (P=0.002) were predictive factors of incidental gallbladder cancer. CONCLUSION Cholecystectomy is suggested for patients with these predictive factors and intraoperative frozen section should be considered to rule out carcinoma.


Journal of International Medical Research | 2016

Segmental portal/superior mesenteric vein resection and reconstruction with the iliac vein after pancreatoduodenectomy

Xin Zhao; Li-Xin Li; Hua Fan; Jiantao Kou; Xian-Liang Li; Ren Lang; Qiang He

Objective The results of segmental venous resection (VR) combined with pancreatoduodenectomy (PD) are controversial but may be promising. Few studies have described reconstruction of the portal/superior mesenteric vein (PV/SMV) with the iliac vein harvested from donation after cardiac death (DCD). Methods From January 2014 to April 2016, PD combined with segmental excision of the PV/SMV (VR group) was performed in 21 patients with adenocarcinoma of the head of the pancreas (ADHP). The authors established a new technique of venous reconstruction using the iliac vein from DCD and analysed patients’ long-term survival. Results The tumour dimensions and tumour staging were greater and the operation time was longer in the VR than PD group; however, no differences in the resection degree, blood loss, complications, reoperation rate, or mortality rate were found. The median survival was similar between the VR and PD groups. The long-term patency of the donor iliac vein was 90%. The degree of resection was a strong predictor of long-term survival. Conclusion Segmental PV/SMV resection combined with PD is applicable to selective patients with venous invasion by ADHP if R0 resection has probably been achieved. An iliac vein obtained by DCD provides an effective graft for venous reconstruction.


RSC Advances | 2015

Sensitive proteolysis assay based on the detection of a highly characteristic solid-state process

Hua Fan; Jiantao Kou; Dongdong Han; Ping Li; Dong Zhang; Qiao Wu; Qiang He

This paper reported a sensitive proteolysis assay based on the detection of a highly characteristic solid-state process. In this study, acetylated peptides at the N-terminal were employed as the blockers of electrochemical signals. Silver nanoparticles (AgNPs) were used as electrochemical species which provided significant stripping current peaks. In the presence of proteases, the designed peptides could be cleaved and released amino groups which interacted with AgNPs and located the electrochemical species on the electrode. By detecting the linear sweep voltammetry, proteolysis processes could be sensitively monitored. We took trypsin and caspase-3 as two examples of proteases. This biosensing platform performed well towards the detection of both proteases. The detection limit for trypsin was 0.2 ng mL−1, and 0.1 pg mL−1 for caspase-3. Moreover, by changing the sequences of the substrate peptide, this method could be applied to detect different proteases. The utility in real samples was also checked with satisfactory results. Therefore, this method might have great potential use for the analysis of proteolysis and could be applied in clinical diagnostics.


International Journal of Surgery | 2018

Proposed Chaoyang vascular classification for superior mesenteric-portal vein invasion, resection, and reconstruction in patients with pancreatic head cancer during pancreaticoduodenectomy – A retrospective cohort study

Jiqiao Zhu; Xian-Liang Li; Jiantao Kou; Jun Ma; Li-Xin Li; Hua Fan; Ren Lang; Qiang He

BACKGROUND Patients with pancreatic head cancer involving the superior mesenteric-portal vein can benefit from vascular resection and reconstruction. We aimed to propose our vascular classification and assess its effect in this study. MATERIAL AND METHODS Data of consecutive patients, who were diagnosed with pancreatic head cancer, and underwent radical pancreaticoduodenectomy combined with superior mesenteric-portal vein resection and reconstruction at our institute between October 2013 and August 2016, were retrospectively collected. On a scale of one to four, our classification was proposed. Perioperative parameters were then analyzed among the four types. RESULTS There were a total of 52 patients with 11 in type Ⅰ, 15 in type Ⅱ, 18 in type Ⅲ, 8 in type Ⅳ. The respective operative time and estimated blood loss of types Ⅲ (425-990 min, 265-1820 mL) and Ⅳ (480-1036 min, 330-1690 mL) were greater than those of types Ⅰ (300-824 min, 200-1255 mL) and Ⅱ (369-875 min, 305-1400 mL) (p < 0.05). Type Ⅳ had larger tumors (4-7 cm) than type Ⅰ (1.5-4 cm) (p < 0.05). Percentage of tunica intima involvement and the median survival time of type Ⅰ (9.1%, 22 months) were lower and longer than those of types Ⅱ (46.7%, 17 months) and Ⅲ (44.4%, 16 months; p < 0.05), and even lower and longer than those of type Ⅳ (87.5%, 10 months; p < 0.01), respectively. CONCLUSIONS Our classification can provide a system to grade patients with venous invasion in order of surgical difficulty and survival.


Current Medical Science | 2017

Treatment of retrogastric pancreatic pseudocysts by laparoscopic transgastric cystogastrostomy

Tian-ming Wu; Zhong-Kui Jin; Qiang He; Xin Zhao; Jiantao Kou; Hua Fan

SummaryThis paper discusses variations of laparoscopic transgastric cystogastrostomy in management of retrogastric pancreatic pseudocysts for 8 patients with symptom or pseudocysts (larger than 6 cm) companied with clinical manifestations. Using a Harmonic scalpel, two 3–5-cm incisions were made in the anterior and posterior gastric wall respectively. In the last step, the anterior gastrotomy was closed with an Endo-GIA stapler. All cases were successfully treated without large blood loss and without conversion to open surgery. The mean operative time was 114.29±19.24 min, blood loss was 157.14±78.70 mL, and mean hospital stay was 8.29±2.98 days. Gastric fistula occurred in one case on the postoperative day 7, and closed 1 month later. No bleeding was seen in all patients during the perioperative follow-up period. CT scans, given one month after the surgeries, displayed that the pancreatic pseudocysts disappeared or decreased in size, and ultrasounds showed no fluid or food residue in stomas at the third and fifth month following surgery. No patient experienced a recurrence during the follow-up period. Transgastric laparoscopic cystogastrostomy is a minimally invasive surgical procedure with a high rate of success and a low rate of recurrence, accompanied by rapid recovery. It is easy to master, safe to perform and may be the preferred option to treat retrogastric pancreatic pseudocysts.This paper discusses variations of laparoscopic transgastric cystogastrostomy in management of retrogastric pancreatic pseudocysts for 8 patients with symptom or pseudocysts (larger than 6 cm) companied with clinical manifestations. Using a Harmonic scalpel, two 3–5-cm incisions were made in the anterior and posterior gastric wall respectively. In the last step, the anterior gastrotomy was closed with an Endo-GIA stapler. All cases were successfully treated without large blood loss and without conversion to open surgery. The mean operative time was 114.29±19.24 min, blood loss was 157.14±78.70 mL, and mean hospital stay was 8.29±2.98 days. Gastric fistula occurred in one case on the postoperative day 7, and closed 1 month later. No bleeding was seen in all patients during the perioperative follow-up period. CT scans, given one month after the surgeries, displayed that the pancreatic pseudocysts disappeared or decreased in size, and ultrasounds showed no fluid or food residue in stomas at the third and fifth month following surgery. No patient experienced a recurrence during the follow-up period. Transgastric laparoscopic cystogastrostomy is a minimally invasive surgical procedure with a high rate of success and a low rate of recurrence, accompanied by rapid recovery. It is easy to master, safe to perform and may be the preferred option to treat retrogastric pancreatic pseudocysts.


Clinics and Research in Hepatology and Gastroenterology | 2017

Isolated hepatic tuberculosis in the caudate lobe mimicking intrahepatic carcinoma

Huanye Liu; Jiqiao Zhu; Hongmeng Dong; Ying Wang; Jun Ma; Jiantao Kou; Xian-Liang Li; Qiang He

Although tuberculosis (TB) remains a worldwide epidemic, isolated hepatic TB is an extremely rare entity and poorly described in the literature. Isolated hepatic TB may pose a diagnostic dilemma due to the non-specific clinical symptoms and imaging features. We present a case of a 54-year-old female with an isolated caseating granulomatous lesion at the caudate lobe of liver involving the pancreatic head.

Collaboration


Dive into the Jiantao Kou's collaboration.

Top Co-Authors

Avatar

Qiang He

Capital Medical University

View shared research outputs
Top Co-Authors

Avatar

Hua Fan

Capital Medical University

View shared research outputs
Top Co-Authors

Avatar

Xian-Liang Li

Capital Medical University

View shared research outputs
Top Co-Authors

Avatar

Jiqiao Zhu

Capital Medical University

View shared research outputs
Top Co-Authors

Avatar

Dongdong Han

Capital Medical University

View shared research outputs
Top Co-Authors

Avatar

Jun Ma

Capital Medical University

View shared research outputs
Top Co-Authors

Avatar

Ping Li

Capital Medical University

View shared research outputs
Top Co-Authors

Avatar

Li-Xin Li

Capital Medical University

View shared research outputs
Top Co-Authors

Avatar

Ren Lang

Capital Medical University

View shared research outputs
Top Co-Authors

Avatar

Hongmeng Dong

Capital Medical University

View shared research outputs
Researchain Logo
Decentralizing Knowledge